Cardiac Autophagy in Sepsis
AbstractSepsis is a leading cause of death in intensive care units, and cardiac dysfunction is an identified serious component of the multi-organ failure associated with this critical condition. This review summarized the current discoveries and hypotheses of how autophagy changes in the heart during sepsis and the underlying mechanisms. Recent investigations suggest that specific activation of autophagy initiation factor Beclin-1 has a potential to protect cardiac mitochondria, attenuate inflammation, and improve cardiac function in sepsis. Accordingly, pharmacological interventions targeting this pathway have a potential to become an effective approach to control sepsis outcomes. The role of autophagy during sepsis pathogenesis has been under intensive investigation in recent years. It is expected that developing therapeutic approaches with specificities targeting at autophagy regulatory factors may provide new opportunities to alleviate organ dysfunction caused by maladaptive autophagy during sepsis. View Full-Text
Share & Cite This Article
Sun, Y.; Cai, Y.; Zang, Q.S. Cardiac Autophagy in Sepsis. Cells 2019, 8, 141.
Sun Y, Cai Y, Zang QS. Cardiac Autophagy in Sepsis. Cells. 2019; 8(2):141.Chicago/Turabian Style
Sun, Yuxiao; Cai, Ying; Zang, Qun S. 2019. "Cardiac Autophagy in Sepsis." Cells 8, no. 2: 141.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.